HomePVLA • NASDAQ
add
Palvella Therapeutics Inc
Previous close
$58.45
Day range
$54.83 - $59.32
Year range
$11.17 - $61.48
Market cap
628.63M USD
Avg Volume
121.08K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 9.25M | 218.09% |
Net income | -9.47M | -127.01% |
Net profit margin | — | — |
Earnings per share | -0.86 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 70.43M | 384.51% |
Total assets | 73.75M | 380.62% |
Total liabilities | 25.97M | 1.56% |
Total equity | 47.78M | — |
Shares outstanding | 11.06M | — |
Price to book | 13.53 | — |
Return on assets | -30.19% | — |
Return on capital | -35.30% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -9.47M | -127.01% |
Cash from operations | -5.43M | -238.99% |
Cash from investing | — | — |
Cash from financing | 349.00K | -96.47% |
Net change in cash | -5.19M | -162.65% |
Free cash flow | -4.06M | — |
About
Website
Employees
14
